KPA Requests Post-Marketing Surveillance on Roche Korea's Caldivita
Published: 2005-03-23 06:57:00
Updated: 2005-03-23 06:57:00
The Korea Pharmaceutical Association (KPA) announced on March 21st that it has submitted a request to the Korea Food and Drug Association (KFDA) for an undertaking of post-marketing surveillance on the alleged substandard product qualities of Roche Korea's Caldivita.
The request is based on th...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
